Market revenue in 2022 | USD 428.0 million |
Market revenue in 2030 | USD 1,048.6 million |
Growth rate | 11.9% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 21.21% in 2022. Horizon Databook has segmented the India biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The biopharma plastics market in India is expected to witness high growth owing to the government’s efforts to improve public health conditions. In addition, increasing private participation in the healthcare industry is expected to fuel the demand for high-quality biopharma plastic devices and components.
This can further contribute to the growing healthcare industry in India and positively impact the biopharma plastics market. According to India Brand Equity Foundation (IBEF), in 2021, India’s public expenditure on healthcare stood at 1.2% of the GDP.
Increasing government expenditure on public health, increasing population, and rapidly growing private participation in the healthcare industry is expected to drive the biopharma plastics market over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the India biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into India biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account